SNP318

Asset

Stage
Phase 2
Modality
Small molecule
Target
Not known
4
Indications
2
Trials
1
Developer

Trial NCT07199777 is still running. Trial NCT07199777 started on Nov 1, 2025. clinicaltrials.gov

Indications

4

1 more

In the full profile

  • Owner and partners1
  • Trials2
  • Competitors12

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets